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Background/aim: The artificial urinary sphincter (AUS) is still one of the best options for incontinence treatment. It may also have an
advantage for revision or reimplantation in the management of complications. In this study we aimed to discuss the etiological factors
for AUS reimplantation and effects of these etiological factors on success rates, patient satisfaction rates, time to reimplantation surgery,
and complications.
Materials and methods: Data from 30 patients for whom AUS reimplantation was performed were analyzed retrospectively. Incontinence
due to fluid loss from the cuff or reservoir balloon, inability of the cuff to adequately compress the urethra, and devices that were thought
to have completed their lifespans were defined as mechanical reasons while incontinence caused by conditions such as cuff erosion and
infection were defined as nonmechanical reasons. Patients who went through reimplantation due to mechanical and nonmechanical
causes were included in Group 1 and Group 2, respectively. Success rates, patient satisfaction rates, time between the implantation of the
first and second AUS, and complications were compared between the groups.
Results: The mean follow-up period was 79 (3–308) months for patients who went through primary AUS implantation due to
postprostatectomy incontinence. Our success rates were found as 75% and 66% in Group 1 and Group 2, respectively. The differences
between the groups in terms of success and patient satisfaction rates were not statistically significant, while the time to reimplantation
was longer in Group 1 and statistically significant.
Conclusion: Reasons for AUS reimplantation may affect the success and patient satisfaction rates. Our success rates of AUS performed
for nonmechanical reasons were slightly lower, but not statistically significantly so. AUS reimplantation may take a longer time if
mechanical failure is detected.
Key words: Urethra, prostatectomy, urinary sphincter, artificial

1. Introduction
Urinary incontinence is a major health problem that
affects the quality of life of affected individuals. Several
epidemiological studies have shown that it arises due to
lower urinary tract symptoms and has incidence rates of
10% and 21% in men under 65 years of age and over 65
years of age, respectively (1–3). Urinary incontinence often
occurs as a complication after radical prostatectomy (RP)
or various endoscopic procedures. It has incidence rates of
5%–48% after RP (1,4). In addition, detrusor overactivity
and de novo bladder compliance impairment can occur in
77% and 50% of RP cases, respectively, particularly in the
first-year follow-up visit after the procedure (5). Factors
such as age, body mass index, urethral length, preoperative

bladder compliance, and sphincter preoperative status
affect the occurrence of postprostatectomy incontinence
(6,7). The experience and surgical skills of surgeons are
other significant factors that can affect the occurrence of
postprostatectomy incontinence (6,7).
Conservative treatment, medical treatment, and surgery
are options for the management of postprostatectomy
incontinence. Although urethral injections, slings, and
synthetic tapes are options in surgical intervention for
incontinence, an artificial urinary sphincter (AUS)
still remains the gold standard in the treatment of
postprostatectomy incontinence (8). In recent years, the
development of novel diagnostic and treatment methods
have made it possible to diagnose and treat patients with
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prostate cancer early (9,10). The main advantage of an
AUS is that its use allows revision and reimplantation. The
mechanical failure of an AUS, infections, cuff erosion, and
iatrogenic factors are factors than can cause incontinence
and repeat incontinence surgery.
Therefore, this study aimed to examine the effects
of etiological factors on the success and satisfaction
rates of AUS reimplantation cases, the time between the
implantation of the first and second AUS (reimplantation),
and complications of AUS in patients undergoing
reimplantation.
2. Materials and methods
Data from 105 patients who had undergone AUS (AMS
800, Minnetonka, MN, USA) implantation between 1990
and 2017 were retrospectively analyzed. All patients had
undergone AUS implantation by the same surgeon. Thirty
of them required reimplantation. Prior to reimplantation,
informed consent was obtained from all patients. All
patients were then administered hemodynamic tests,
urinalysis, ultrasonic examination, and cystoscopy
preoperatively. When necessary, urodynamic testing,
intravenous urography, and retrograde urethrography
were performed. Cases of incontinence caused by the loss
of the cuff or fluid from the reservoir balloon, inability of
the cuff to adequately compress the urethra, and situations
where the device seemed to have completed its lifespan
were defined as mechanical causes. Cases of incontinence
caused by conditions such as cuff erosion and infection
were defined as nonmechanical causes. Patients who
underwent reimplantation due to mechanical and
nonmechanical causes were included in Group 1 and
Group 2, respectively.
Criteria for AUS reimplantation included incontinence
affecting the quality of life of a patient and the absence
of new factors such as mental or physical disorders,
conditions that would not constitute a pathology for the
lower urinary tract with a high expectancy of life for AUS
mapping or reimplantation, unexpected recurrence, and
those who still maintained adequate bladder capacity.
2.1. Surgical technique
We waited for 6 months to reimplant a new device in
the case of infection. In cases of mechanical failure or
lack of active infection, simultaneous displacement
and reimplantation or reoperation was performed.
Prophylactic antibiotic treatment was initiated before
the procedure. All of our patients in this study were
approached with a perineal incision after placing the
appropriate urethral catheter in lithotomy position.
Bulbospongiosus and bulbocavernosus muscles were
dissected from the bulbar urethra and attempts were made
to determine the pathology necessitating reimplantation.
First, we tried to change only the corrupted instrument of
the device (urethral cuff, reservoir, pump, etc.). However,
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if this was not possible and total replacement of the device
was planned, urethral mobilization was attempted. It was
passed under the bulbous urethra with the help of a rightangle clamp. The diameter of the urethra was determined
for the appropriate urethral cuff. At this point, an attempt
was made to avoid extreme dissection of the urethra and
giving the cuff too much tension. We aimed to support the
urethra with the adjacent connective tissues in order to
avoid urethral atrophy. The air of the device was evacuated
and the instruments were placed appropriately. An inguinal
oblique incision was made for reservoir placement. The
reservoir was placed in the retropubic area and the cuff
and conducting tubes were connected. The reservoir was
filled with 22 mL of saline. Subdartos space was then
prepared for the pump. The cuff was properly assembled
by passing the connector tubing under the scarpa fascia
so as to provide the space between the reservoir and the
pump. After all instruments were checked, the reservoir
was filled and deactivated. A Penrose drain was placed
into the scrotum. The layers were closed in accordance
with the procedure. Urethral catheters of all patients were
removed 24 h postoperatively. For preventing edema
and hematoma we applied cold scrotal elevation for 6 h.
Patients were discharged at an average of 6 (range: 4–8)
days with pad use advice. We called all patients back 6
weeks after the surgery for device activation. All patients
were examined 1, 3, 6, and 12 months after the activation.
Data on postoperative incontinence level, daily pad usage,
and quality of life parameters were recorded.
The degree and amount of incontinence and the quality
of life of the patients were evaluated using the International
Consultation on Incontinence Questionnaire-Urinary
Incontinence Short Form (ICIQ-UI SF), a pad test, and the
fifth question of the ICIQ-UI SF, respectively. Data such
as postoperative incontinence level, pad requirements,
and quality of life scores were recorded. Complete dryness
or using less than one pad per day was regarded as social
continence, while usage of more than one pad per day was
regarded as incontinence.
2.2. Statistical analysis
Data were analyzed with IBM SPSS Statistics 21. Descriptive
statistics are shown as mean ± standard deviation for
variables with normal distribution and as median (min–
max) for variables with abnormal distribution. Nominal
variables are shown as number of cases and (%). The
t-test and Mann–Whitney U test were used in order
to determine degree of significance for parametric and
nonparametric variables, respectively. Success rates
between the groups were evaluated by Fisher’s exact test. P
< 0.05 was considered statistically significant.
3. Results
The mean follow-up period was 79 months (range: 3–308
months) for patients who underwent primary AUS
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implantation due to postprostatectomy incontinence. The
mean age of the patients was 61.7 years (range: 15–70 years)
and 67.6 years (range: 38–79 years) in Group 1 and Group
2, respectively. The overall rate of AUS reimplantation was
28.5%, and the causes for reimplantation were mechanical
and nonmechanical in 40% and 60% of those patients,
respectively (Table 1). Twelve patients in Group 1 were
readmitted within a mean of 136 months (range: 14–276
months) after the first AUS implantation, while 18 patients
in Group 2 were readmitted within a mean of 55 months
(range: 3–192 months) after the first AUS implantation.
The causes of incontinence were reservoir discharge or
urethral cuff in all patients in Group 1 (Table 1). In Group
2, four patients had infection due to scrotal erosion by
the pump, six patients had cuff erosion due to attempts
to place urethral catheters for urological or nonurological
conditions, and the remaining eight patients had cuff
erosions and secondary infections that were caused by
factors such as age or comorbidities that had affected
urethral blood flow (Table 1).
The success rates were 75% and 66% in Group 1 (9
patients became continent) and Group 2 (12 patients
became continent), respectively. On the other hand, three
and six patients remained incontinent in Group 1 and
Group 2, respectively. In the six unsuccessful patients
in Group 2, the reasons for AUS removal were scrotal
erosion by the pump in one patient and infections due to
cuff erosion in two patients. Intraoperatively, we noticed
leakage from the transfer pipes of the device that failed
after reimplantation in one of the three patients in Group
1. We performed another operation after 3 months and
changed the device. As a result, in Group 1, transfer
tubes was changed in one patient, a tandem cuff was
placed in one patient, reservoir balloons were changed
in two patients, and the rest had their devices completely
replaced. Two patients stated that incontinence did not
affect their quality of life and they did not want to undergo
a third surgery. Follow-up of these patients is still ongoing.
In Group 2, three of the six patients had cuff erosion, while
the others had perineal or scrotal infections; therefore, we
Table 1. AUS reimplantation etiology.
Etiology

Patients

Mechanical

12 (40%)

Urethral cuff empty

8 (26.6%)

Reservoir discharge

4 (13.3%)

Nonmechanical

18 (60%)

Traumatic urethral catheterization

6 (20%)

Cuff erosion

6 (20%)

Infection

6 (20%)

removed the device. Three of these patients had undergone
a third AUS implantation surgery 6 months after discharge
and achieved continence. The other three patients did not
consent to a third surgery.
The mean number of pads used daily was 1.04 ± 1.61 in
Group 1 and 1.38 ± 1.72 in Group 2. The mean symptom
score (ICIQ-UI SF) was 4.00 ± 3.07 in Group 1 and 5.61
± 4.96 in Group 2. The quality of life score (ICIQ-UI SF,
fifth question) was 3.33 ± 2.90 in Group 1 and 4.00 ±
2.76 in Group 2. Patient outcomes were better, but not
statistically significantly so, in Group 1 in terms of success
rates, postoperative symptom scores, average daily use
of pads, and quality of life scores (Table 2). The time for
reimplantation was longer and statistically significant in
Group 1 (Table 2).
4. Discussion
Despite all technological advancements in the field of
medicine, incontinence still remains a problem in the
field of urology. Although developments in surgical
techniques are expected to reduce the incidence rate of
postprostatectomy incontinence (11), the increase in the
number of prostatectomy cases has caused the incidence
rate to remain stable (12). In spite of the high success rates
of AUS implantations, reimplantation or revision is not
rare. In the literature, it was recorded that the success rate
of AUS implantation is over 80% (13–15), regardless of the
severity of incontinence, and that 37%–50% of patients
would need revision in the first 10 years (14,16). Urethral
atrophy has been reported as the most common cause of
revision surgery and recurrent incontinence in various
studies (17,18). In another study, the total rate of revision
was reported to be 30.5% in the first 3 years and the reasons
were cuff erosion in 12%, infection in 4%, and mechanical
failure in 14% of the cases (15). In the literature, research
studies on the etiology and success rates of AUS are
limited. The success rate of AUS revision was reported
as 82% in a study of 119 cases, similar to the results of
primary and secondary AUS implantation success rates
(19). Tuygun et al. compared male bulbourethral slings
and AUS reimplantation in patients with erosions after
primary implantation. They reported that AUS resulted in
better patient outcomes than bulbourethral slings (20). In
another study (21), a success rate of 75% was documented
in patients who had undergone AUS reimplantation due to
infection. Studies mentioned in the literature did not take
etiology into consideration in the assessment of success
rates of AUS reimplantation. In our study, the success rate
in Group 1 was similar to those found in the literature, while
in Group 2 it was lower than those in the literature. It has
been suggested that nonmechanical causes of continence
lead to ischemia of the periurethral area and connective
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Table 2. Comparison of parameters between groups.
Parameters

Group1 (n: 12)

Group2 (n: 18)

P

Dryness

9 (75%)

12 (66.6%)

0.704

Time to reimplantation (months)

136 (14–276)

55 (3–192)

0.0312

Mean amount of pads (daily)

1.04 ± 1.61

1.38 ± 1.72

0.408

Mean symptom score (ICIQ-UI SF)

4.00 ± 3.07

5.61 ± 4.96

0.639

Quality of life (ICIQ-UI SF) (5th question)

3.33 ± 2.90

4.00 ± 2.76

0.456

tissues that the cuff is placed in and, consequently, a higher
potential for urethral trauma. Our reimplantation rate was
slightly lower than the rates documented in the literature.
We suggest that the lower rates were due to differences in
etiological factors, follow-up duration, and other patientbased factors.
It is often not possible to predict the diagnosis of
urethral atrophy in advance. In the literature there is still no
consensus on this issue (22). In general, this may be noticed
when the urethral cuff is placed during surgery, requiring
a narrower cuff than before (22). Since AUS surgeries are
mostly performed on elderly patients, these patients may
have various chronic progressive systemic diseases that
may increase with age, destroy the urethral blood flow,
or cause atrophy. In addition, excessive squeezing of the
urethral cuff placement during the first AUS implantation
can cause urethral disruption and atrophy.
We observed that the most common causes of AUS
reimplantation were urethral atrophy, cuff erosion due to
urethral interventions, and nonmechanical causes such as
infections. Therefore, AUS-implanted patients should be
educated on the use of the device and possible urethral
interventions. There are studies in the literature that have
predicted AUS reimplantation rates and complications. In
this sense, some studies in the literature have correlated
AUS infection or erosion with the history of radiotherapy or
comorbidities (21,23). Similarly, erosion has been reported
to increase the risk of reimplantation up to four times (24).
In reoperations performed due to erosion or infection,
tissue structures may deteriorate because of scar tissue and
fibrosis (23). Scar tissue may impair vascularization and
create a vicious circle by causing reinfection or erosion.
In our study, there were no patients with a history of
radiotherapy or any clinically significant comorbidity. Our
rates of success, patient satisfaction, and incontinence were
lower in patients with incontinence due to nonmechanical
causes, and the AUS was removed in three patients due
to developing infections. These results suggested that
infection in the periurethral area or fibrosis due to urinary
extravasation increases due to insufficiency of the cuff to
squeeze the urethra or excessive urethral dissection.

1266

It has been reported that mechanical failures of the AUS
can lead to AUS reimplantation or revision less commonly
than other known reasons (21). These mechanical failures
are frequently associated with obesity (21). Furthermore,
urethral atrophy and mechanical failure have been reported
as factors that cause recurrent urinary incontinence
(16,21). There were no morbidly obese patients in our
study. Mechanical failures were commonly related to
devices that had completed their lifespans. In addition,
success and patient satisfaction rates were better, but not
statistically significantly so, in Group 2. When compared
with nonmechanical causes, mechanical causes of AUS
reimplantation may lead to minimal urethral damage.
The time frame within which the need for AUS
reimplantation or revision arises may give a clue to the
etiology of incontinence. In this sense, incontinence
that occurred in the first week or month after the first
AUS implantation may reveal an unrecognized urethral
injury that might have occurred during cuff insertion,
while late-onset incontinence suggests improper device
use, long-term catheterization, or urethral interventions
without device deactivation (16). In our study, the time
for reimplantation was longer and statistically significant
in patients with incontinence due to mechanical causes.
It is essential to manage the nonmechanical causes of
incontinence to reduce the need for reimplantation and
to extend the lifespan of the device. Therefore, patients
should be taught to use the device properly and the device
should be deactivated before urethral interventions.
As a result, it may not be possible to predict AUS
complications. However, we think that it is important to
warn patients and their relatives about possible urethral
interventions to be applied and to teach the operating
principles of the device to the patient in detail. In addition,
we think that it is also important to avoid excessive
dissection of the urethra and excessive cuff squeezing
during surgery, and to give the necessary importance to
sterility during and after surgery.
In conclusion, an AUS is a useful device that allows
reimplantation and revision in incontinence surgery.
However, several etiological factors may affect the
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success and complication rates of an AUS. While it may
not be possible to predict mechanical failures, it may be
possible to predict and manage nonmechanical causes.
Therefore, it is essential to explain the use of the device
to patients, and both patients and physicians should be
educated on urethral interventions. Although the success

and satisfaction rates of AUS reimplantation performed
for nonmechanical causes were reported to be low,
further clinical studies with a larger number of patients
are required to obtain more data that can be more widely
generalized.
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